Advertisement for orthosearch.org.uk
Results 1 - 12 of 12
Results per page:
Bone & Joint 360
Vol. 9, Issue 1 | Pages 10 - 14
1 Feb 2020
Ibrahim M Reito A Pidgaiska O


Bone & Joint 360
Vol. 8, Issue 4 | Pages 37 - 39
1 Aug 2019


Bone & Joint 360
Vol. 8, Issue 3 | Pages 35 - 37
1 Jun 2019


The Bone & Joint Journal
Vol. 101-B, Issue 3 | Pages 266 - 271
1 Mar 2019
Laitinen MK Parry MC Le Nail L Wigley CH Stevenson JD Jeys LM

Aims

The purpose of this study was to investigate the potential for achieving local and systemic control after local recurrence of a chondrosarcoma of bone

Patients and Methods

A total of 126 patients with local recurrence (LR) of chondrosarcoma (CS) of the pelvis or a limb bone were identified from a prospectively maintained database, between 1990 and 2015 at the Royal Orthopaedic Hospital, Birmingham, United Kingdom. There were 44 female patients (35%) and 82 male patients (65%) with a mean age at the time of LR of 56 years (13 to 96). The 126 patients represented 24.3% of the total number of patients with a primary CS (519) who had been treated during this period. Clinical data collected at the time of primary tumour and LR included the site (appendicular, extremity, or pelvis); primary and LR tumour size (in centimetres); type of operation at the time of primary or LR (limb-salvage or amputation); surgical margin achieved at resection of the primary tumour and the LR; grade of the primary tumour and the LR; gender; age; and oncological outcomes, including local recurrence-free survival and disease-specific survival. A minimum two years’ follow-up and complete histopathology records were available for all patients included in the study.


The Bone & Joint Journal
Vol. 99-B, Issue 5 | Pages 686 - 696
1 May 2017
Stihsen C Panotopoulos J Puchner SE Sevelda F Kaider A Windhager R Funovics PT

Aims

Few studies dealing with chondrosarcoma of the pelvis are currently available. Different data about the overall survival and prognostic factors have been published but without a detailed analysis of surgery-related complications. We aimed to analyse the outcome of a series of pelvic chondrosarcomas treated at a single institution, with particular attention to the prognostic factors. Based on a competing risk model, our objective was to identify risk factors for the development of complications.

Patients and Methods

In a retrospective single-centre study, 58 chondrosarcomas (26 patients alive, 32 patients dead) of the pelvis were reviewed. The mean follow-up was 13 years (one week to 23.1 years).


Bone & Joint 360
Vol. 4, Issue 5 | Pages 25 - 26
1 Oct 2015

The October 2015 Oncology Roundup360 looks at: Radiotherapy for the radioresistant; Multiple hereditary exostosis; The total femur as a limb salvage option; Survival prediction in osteosarcoma; What happens when chondrosarcoma recurs?; Thumbs up for vascularised fibular graft; Radiotherapy and survival; Musculoskeletal tumours in pregnancy


Bone & Joint 360
Vol. 1, Issue 3 | Pages 26 - 28
1 Jun 2012

The June 2012 Oncology Roundup. 360. looks at: avoiding pelvic hemipelvectomy; proximal femoral metastasis; extendible prostheses; rotationplasty; soft-tissue sarcomas; osteosarcoma of the pelvis; recurrent chondrosarcoma ; MRI and the differentiation between benign and malignant lesions; and malignant fibrous histiocytoma


Orthopaedic Proceedings
Vol. 94-B, Issue SUPP_XIV | Pages 52 - 52
1 Apr 2012
Ruggieri P Angelini A Abati C Drago G Errani C Mercuri M
Full Access

Aim. To evaluate outcome and complications of knee arthrodesis with a modular prosthetic system (MUTARS(r) Implantcast), as primary and revision implants in musculoskeletal oncology. Method. Between 1975 and 2009, 24 prostheses were used for knee arthrodesis. Nineteen in oncologic cases: 6 osteosarcomas, chondrosarcoma, synovial sarcoma and metastatic carcinoma 3 each, 2 pigmented villonodular synovitis (PVNS), malignant fibrous hystiocitoma and giant cell tumour 1 each. Patients were grouped into: A) primary implants, B) revision implants. Group A included 9 patients: 8 arthrodeses after extra-articular resection with major soft tissue removal, 1 after primary resection following multiple excisions of locally recurrent PVNS. Group B included 15 patients: 12 arthrodeses for infection (5 infected TKAs, 7 infected megaprostheses), 2 for failures of temporary arthodesis with Kuntscher nail and cement, 1 for recurrent chondrosarcoma in previous arthrodesis. Results. Oncologic outcome ata mean follow-up of 6 years (ranging 1 to 26), showed 13 NED (68.4%), 2 NED after treatment of relapse (10.5%), 1 alive with metastases (5.3%), 2 dead with disease (10.5%) and one dead of other disease (5.3%). Complications causing failure were observed in 12 patients (50%): 11 infections at mean of 14 months (6 in arthrodeses as revision for previous infections, 5 in group A), 1 femoral stem breakage at 4.8 years (in group B). Treatment of infections was: amputation in 6, “one stage” in 1, “two stage” with new arthrodesis in 4 (1 subsequently amputated for recurrent infection). The breakage was revised, had further traumatic breakage at 2 years and a second revision. Conclusion. Arthrodesis with modular prosthetic system is indicated after major extra-articular resection or in revisions of severely failed previous reconstructions. High infection rate should be prevented with good soft tissue coverage, by flaps if needed


The Journal of Bone & Joint Surgery British Volume
Vol. 94-B, Issue 1 | Pages 122 - 127
1 Jan 2012
Streitbuerger A Ahrens H Gosheger G Henrichs M Balke M Dieckmann R Hardes J

The aim of this study was to define the treatment criteria for patients with recurrent chondrosarcoma. We reviewed the data of 77 patients to examine the influence of factors such as the intention of treatment (curative/palliative), extent of surgery, resection margins, status of disease at the time of local recurrence and the grade of the tumour. A total of 70 patients underwent surgery for recurrent chondrosarcoma. In seven patients surgery was not a viable option. Metastatic disease occurred in 41 patients, appearing synchronously with the local recurrence in 56% of cases. For patients without metastasis at the time of local recurrence, the overall survival at a mean follow-up after recurrence of 67 months (0 to 289) was 74% (5 of 27) compared with 19% (13 of 50) for patients with metastasis at or before the development of the recurrence. Neither the type/extent of surgery, site of tumour, nor the resection margins for the recurrent tumour significantly influenced the overall survival. . With limited survival for patients with metastatic disease at the time of local recurrence (0% for patients with grade III and de-differentiated chondrosarcoma), palliative treatment, including local radiation therapy and debulking procedures, should be discussed with the patients to avoid long hospitalisation and functional deficits. For patients without metastasis at the time of local recurrence, the overall survival of 74% justifies an aggressive approach including wide resection margins and extensive reconstruction


The Journal of Bone & Joint Surgery British Volume
Vol. 93-B, Issue 8 | Pages 1111 - 1117
1 Aug 2011
Sewell MD Hanna SA McGrath A Aston WJS Blunn GW Pollock RC Skinner JA Cannon SR Briggs TWR

The best method of reconstruction after resection of malignant tumours of the tibial diaphysis is unknown. In the absence of any long-term studies analysing the results of intercalary endoprosthetic replacement, we present a retrospective review of 18 patients who underwent limb salvage using a tibial diaphyseal endoprosthetic replacement following excision of a malignant bone tumour. There were ten men and eight women with a mean age of 42.5 years (16 to 76). Mean follow-up was 58.5 months (20 to 141) for all patients and 69.3 months (20 to 141) for the 12 patients still alive. Cumulative patient survival was 59% (95% confidence interval (CI) 32 to 84) at five years. Implant survival was 63% (95% CI 35 to 90) at ten years. Four patients required revision to a proximal tibial replacement at a mean follow-up of 29 months (10 to 54). Complications included metastases in five patients, aseptic loosening in four, peri-prosthetic fracture in two, infection in one and local recurrence in one. The mean Musculoskeletal Tumor Society score and the mean Toronto Extremity Salvage Score were 23 (17 to 28) and 74% (53 to 91), respectively.

Although rates of complication and revision were high, custom-made tibial diaphyseal replacement following resection of malignant bone tumours enables early return to function and provides an attractive alternative to other surgical options, without apparent compromise of patient survival.


The Journal of Bone & Joint Surgery British Volume
Vol. 87-B, Issue 11 | Pages 1527 - 1530
1 Nov 2005
Donati D Ghoneimy AE Bertoni F Di Bella C Mercuri M

We reviewed 124 patients with a conventional pelvic chondrosarcoma who had been treated over a period of 20 years. We recorded the type of tumour (central or peripheral), type of operation (limb salvage surgery or hemipelvectomy), the grade of tumour, local recurrence and/or metastases, in order to identify the factors which might influence survival.

More satisfactory surgical margins were achieved for central tumours or in those patients treated by hemipelvectomy. However, grade 1 tumours, whatever the course, did not develope metastases or cause death, while grade 3 tumours had the worst outcome and prognosis.

Central, high-grade tumours require aggressive surgical treatment in order to achieve adequate surgical margins, particularly in those lesions located close to the sacroiliac joint. By contrast, grade 1 peripheral chondrosarcomas may be treated with contaminated margins in order to reduce operative morbidity, but without reducing survival.


Orthopaedic Proceedings
Vol. 86-B, Issue SUPP_IV | Pages 396 - 396
1 Apr 2004
Ward W
Full Access

Introduction: Pelvic and acetabular reconstruction following tumor resections are often difficult and fraught with complications. This is the first report of a reconstruction utilizing sacral implantation of an acetabular component, a relatively simple procedure. Materials and Methods: A 74 year-old man developed recurrent low-grade chondrosarcoma in his ilium. Prior resections had included total hip reconstruction with massive cemented acetabular components. A combined Type I and II internal hemipelvectomy with endoprosthetic reconstruction were performed. Following resection, his sacrum and a small fragment of remaining ilium at the sacroiliac joint was reamed to accept a 48 mm porous coated acetabular component. It was press- fit into place and further secured with two central and three rim screws. A constrained cup liner was used. A proximal femoral endoprosthesis was constructed from a commercially available modular oncology system. Additional resection of the superior and inferior pubic ramie was required to minimize the likelihood of endoprosthetic impingement and leverage-induced dislocation. A soft tissue reconstruction of the abductors was accomplished. Results: He remains free of recurrence 15 months post-operative. He ambulates full weight bearing with crutches. His leg is neurovascularly intact and he is pleased with his results. A videotape, demonstrating his gait, will be shown. Discussion: The author knows of one similar reconstruction that was performed at another center (unpublished data). That other patient suffered acetabular component dislodgement. The intraoperative leverage-induced dislocation of the hip was the important determination. Pubic rami resection may be required to prevent femoral impingement and instability. The use of multiple fixation screws also improved component fixation. Conclusion: Placement of a well fixed, constrained, acetab-ular component into a retained sacrum at the level of the SI joint provides an alternative limb salvage technique